ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Radius Health Announces Commercial Agreement with Paladin Labs for Abaloparatide in Canada
January 13, 2021Radius Health has entered into definitive agreements with Endo Ventures Limited, a subsidiary of Endo International, to register, commercialize, and distribute abaloparatide on an exclusive basis in Canada. -
Paladin Labs Inc. Announces Approval of Envarsus PA (tacrolimus prolonged-release tablets) in Canada
February 23, 2019Paladin Labs Inc. and Endo Ventures Limited, subsidiaries of Endo International plc (NASDAQ: ENDP), today announced Health Canada's approval of Envarsus PA™(tacrolimus prolonged-release tablets) for the prophylaxis of organ rejection in kidney or liver t
Pharma Sources Insight January 2025
